Rapid Micro Biosystems
RPID
31 hedge funds and large institutions have $34.5M invested in Rapid Micro Biosystems in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 12 closing their positions.
25% more capital invested
Capital invested by funds: $27.7M → $34.5M (+$6.83M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4.52% less ownership
Funds ownership: 67.24% → 62.72% (-4.5%)
26% less funds holding
Funds holding: 42 → 31 (-11)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.89M |
| 2 |
RMC
Resources Management Corp
West Hartford,
Connecticut
|
+$64.3K |
| 3 |
Renaissance Technologies
New York
|
+$52.9K |
| 4 |
Citigroup
New York
|
+$20.2K |
| 5 |
GCM
Glenview Capital Management
New York
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$2.48M |
| 2 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$225K |
| 3 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$212K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$182K |
| 5 |
FAM
Fred Alger Management
New York
|
-$140K |
RPID Hedge Fund Activity: Q1 2023 in Review
31 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q1 2023, worth a combined $34.5M — up 25% from $27.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of RPID and 1 opened new positions — a net loss of 11 holders — while 12 trimmed existing stakes and 6 added.
The largest buyer was JP Morgan Chase, adding an estimated $1.89M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $2.48M sold.
- 31 institutional investors held Rapid Micro Biosystems (RPID) as of Q1 2023, down from 42 in Q4 2022.
- Funds reported $34.5M of Rapid Micro Biosystems stock for Q1 2023, up 25% quarter-over-quarter.
- 1 fund opened new Rapid Micro Biosystems positions in Q1 2023 and 12 closed out, a net change of -11 holders.
- The largest Rapid Micro Biosystems buyer in Q1 2023 was JP Morgan Chase, an estimated $1.89M added.
- The largest Rapid Micro Biosystems seller in Q1 2023 was T. Rowe Price Investment Management, an estimated $2.48M sold.
Based on aggregated 13F filings for Q1 2023.